Immune Checkpoint Inhibitor-Associated Myocarditis: A Rare Presentation With Atrioventricular Block and Sinus Node Dysfunction
Open Access
- 9 September 2023
- Vol. 5 (11) , 829-832
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational ReviewBiology, 2023
- 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)European Heart Journal, 2022
- Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanismsJournal of Clinical Investigation, 2021
- Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk FactorsCurrent Oncology Reports, 2021
- Complete Atrioventricular Block Associated with Pembrolizumab-induced Acute Myocarditis: The Need for Close Cardiac MonitoringInternal Medicine, 2018